94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Divya L. Dayanidhi1,2†
Jason A. Somarelli1†John B. Mantyh1,2Gabrielle Rupprecht1,2Roham Salman Roghani1,2
Sophia Vincoff1Iljin Shin3Yiquan Zhao3
So Young Kim4Shannon McCall5
Jiyong Hong3,6*
David S. Hsu1,2*- 1Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, United States
- 2Center for Genomics and Computational Biology, Duke University, Durham, NC, United States
- 3Department of Chemistry, Duke University, Durham, NC, United States
- 4Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, United States
- 5Department of Pathology, Duke University, Durham, NC, United States
- 6Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, United States
A corrigendum on
Psymberin, a marine-derived natural product, induces cancer cell growth arrest and protein translation inhibition
by Dayanidhi, D. L., Somarelli, J. A., Mantyh, J. B., Rupprecht, G., Roghani, R. S., Vincoff, S., Shin, I., Zhao, Y., Kim, S. Y., McCall. S., Hong, J., and Hsu, D. S. (2022). Front. Med. 9:999004. doi: 10.3389/fmed.2022.999004
In the published article, there was an error in the Funding statement. A funding agency was not included in the Funding statement. The correct Funding statement appears below.
This research was partially supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI19C1343).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: patient-derived organoids, patient-derived models of cancer, precision medicine, psymberin, high-throughput screening, protein translation
Citation: Dayanidhi DL, Somarelli JA, Mantyh JB, Rupprecht G, Roghani RS, Vincoff S, Shin I, Zhao Y, Kim SY, McCall S, Hong J and Hsu DS (2023) Corrigendum: Psymberin, a marine-derived natural product, induces cancer cell growth arrest and protein translation inhibition. Front. Med. 10:1193745. doi: 10.3389/fmed.2023.1193745
Received: 25 March 2023; Accepted: 18 May 2023;
Published: 31 May 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Dayanidhi, Somarelli, Mantyh, Rupprecht, Roghani, Vincoff, Shin, Zhao, Kim, McCall, Hong and Hsu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jiyong Hong, aml5b25nLmhvbmdAZHVrZS5lZHU=; David S. Hsu, c2hpYW93ZW4uaHN1QGR1a2UuZWR1
†These authors have contributed equally to this work